Skip to main content

fda_approval · anda · info

MSN — ANDA approval: DASATINIB (unspecified)

Event date
2026-09-11 00:00:00Z
Observed
2026-09-17 04:30:42Z
Source ID
ANDA219579-1
Payload hash
7dea54d17a50004399e99861

Summary

MSN received ANDA approval for DASATINIB (unspecified) on 2026-09-11. Dosage form: TABLET. Application #: ANDA219579.

Entities

Frequently asked questions

Has MSN had other FDA enforcement actions?
Yes. Argus HQ has recorded 7 total FDA actions tied to MSN: 0 warning letters, 0 recalls, 7 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?
This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-09-11; Argus observed and indexed it on 2026-09-17.
Where can I verify this record directly with FDA?
The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA
Argus HQ Research (2026). MSN — ANDA approval: DASATINIB (unspecified). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-approval-msn-anda219579-1
MLA
"MSN — ANDA approval: DASATINIB (unspecified)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-approval-msn-anda219579-1.
Chicago
Argus HQ Research. "MSN — ANDA approval: DASATINIB (unspecified)." Digital Empire Holdings LLC. Accessed September 17, 2026. https://argushq.ai/events/fda-approval-msn-anda219579-1.
BibTeX
@misc{argushq_argushq_ai_events_fda_approval_msn_anda219579_1_2026,
  title = {MSN — ANDA approval: DASATINIB (unspecified)},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-approval-msn-anda219579-1},
  note = {Accessed: September 17, 2026}
}

Informational only. Not legal, financial, or medical advice.

MSN — ANDA approval: DASATINIB (unspecified) · Argus HQ